Skip to content

13F-HR filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-14, with 67 holding rows worth $207,750,000.

Accession
0001697013-18-000011
Filed
2018-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, 67 entries on the cover page, a total value of $207,750,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $207,750,000 with VALUE read as thousands by filing date, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZOGENIX INC.98978L204Common Stock419,279$20,796,000thousands by filing date
R1 RCM INC749397105COM1,685,087$17,120,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW995,700$16,200,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR280,872$12,547,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR289,284$11,746,000thousands by filing date
Merck & Co.,Inc.58933Y105COM147,800$10,556,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW528,992$9,416,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM48,092$9,269,000thousands by filing date
TELIGENT INC NEW87960W104COM2,112,098$8,343,000thousands by filing date
SPDR S&P 500 ETF TR78462F953PUT900$7,702,000thousands by filing dateput
AERIE PHARMACEUTICALS INC00771V108COM120,711$7,430,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM42,194$6,815,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM43,621$6,161,000thousands by filing date
Abbott Laboratories002824100COM75,100$5,509,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW119,371$5,493,000thousands by filing date
ENSIGN GROUP INC29358P101COM134,655$5,112,000thousands by filing date
Danaher Corporation235851102COM35,604$3,874,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock209,739$2,769,000thousands by filing date
Medtronic PlcG5960L103COM26,800$2,650,000thousands by filing date
ANAPTYSBIO INC032724106COM22,524$2,247,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock9,400$2,013,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS66,600$1,933,000thousands by filing date
AFFIMED N VN01045108COM432,727$1,882,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR23,554$1,786,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM100,295$1,783,000thousands by filing date
ARQULE INC04269E107COM289,618$1,639,000thousands by filing date
INVACARE CORP461203101COMMON STOCK108,902$1,585,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS273,817$1,569,000thousands by filing date
ABIOMED INC003654100COM3,419$1,538,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR19,054$1,350,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM21,900$1,281,000thousands by filing date
MODEL N INC607525102COM72,283$1,146,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock148,959$1,137,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK21,671$994,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM79,750$964,000thousands by filing date
INSULET CORP COM45784P101Stock8,765$929,000thousands by filing date
CARETRUST REIT INC COM14174T107REIT51,264$918,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock60,412$918,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM72,096$799,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM51,074$779,000thousands by filing date
TRICIDA INC89610F101COM24,122$737,000thousands by filing date
ORTHOPEDIATRICS CORP68752L100COMMON STOCK19,600$718,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC CMN STOCK84763A958Cmn600$659,000thousands by filing dateput
DENTSPLY SIRONA INC24906P109COM16,680$631,000thousands by filing date
Elevance Health, Inc.036752103COM2,300$630,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock4,300$623,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK18,029$594,000thousands by filing date
EPIZYME INC29428V104COM47,449$503,000thousands by filing date
MEDICINES CO584688105COM16,717$500,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM44,140$497,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM30,899$481,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM25,000$436,000thousands by filing date
DERMIRA INC24983L104COM40,018$436,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock65,000$364,000thousands by filing date
OPHTHOTECH CORP683745103COM149,100$352,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW27,000$335,000thousands by filing date
CONFORMIS INC20717E101COM126,851$134,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM14,500$106,000thousands by filing date
MELINTA THERAPEUTICS INC58549G100COM26,479$105,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM3,300$66,000thousands by filing date
SANGAMO THERAPEUTICS INC800677906CALL400$47,000thousands by filing datecall
CELYAD ONCOLOGY SA151205200ADR1,676$44,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC CMN STOCK84763A908Cmn400$19,000thousands by filing datecall
FOAMIX PHARMACEUTICALS LTDM46135955PUT250$13,000thousands by filing dateput
CELGENE CORP151020112RIGHT 12/31/20306,000$10,000thousands by filing date
VITAL THERAPIES INC92847R954PUT383$8,000thousands by filing dateput
AKORN INC009728906Cmn16$4,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-18-000011this filing2018-11-14acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000009 base2023-11-08acceptance time not in the bulk data set